2017 | Obesity is more closely related with hepatic steatosis and fibrosis measured by transient elastography than metabolic health status | METABOLISM-CLINICAL AND EXPERIMENTAL |
2012 | Optimal time for restoring the reliability of liver stiffness measurement in patients with chronic hepatitis B experiencing acute exacerbation | JOURNAL OF CLINICAL GASTROENTEROLOGY |
2013 | Orthotopic liver transplantation after the combined use of locoregional therapy and sorafenib for advanced hepatocellular carcinoma
| ONCOTARGETS AND THERAPY |
2009 | Outcome after curative resection for a huge (≥10 cm) hepatocellular carcinoma and prognostic significance of gross tumor classification | AMERICAN JOURNAL OF SURGERY |
2016 | Outcome of adefovir add-on lamivudine rescue therapy of up to 5 years in patients with lamivudine-resistant chronic hepatitis B | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2020 | Outcomes of Long-term Treatment of Chronic HBV Infection With Entecavir or Other Agents From a Randomized Trial in 24 Countries | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
2014 | Overall response of both intrahepatic tumor and portal vein tumor thrombosis is a good prognostic factor for hepatocellular carcinoma patients receiving concurrent chemoradiotherapy
| JOURNAL OF RADIATION RESEARCH |
2023 | Overall survival and objective response in advanced unresectable hepatocellular carcinoma: A subanalysis of the REFLECT study
| JOURNAL OF HEPATOLOGY |
2013 | Partial Virological Response to Adefovir Add-On Lamivudine Rescue Therapy in Patients with Lamivudine-Resistant Chronic Hepatitis B | DIGESTION |
2011 | Partial virological response to entecavir in treatment-naive patients with chronic hepatitis B. | ANTIVIRAL THERAPY |
2013 | Performance evaluation of the HepB Typer-Entecavir kit for detection of entecavir resistance mutations in chronic hepatitis B
| CLINICAL AND MOLECULAR HEPATOLOGY |
2012 | Performance of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B: a meta-analysis
| PLOS ONE |
2008 | Persistent hepatitis B viral replication affects recurrence of hepatocellular carcinoma after curative resection | LIVER INTERNATIONAL |
2021 | Pharmacodynamic Biomarkers Predictive of Survival Benefit with Lenvatinib in Unresectable Hepatocellular Carcinoma: From the Phase III REFLECT Study | CLINICAL CANCER RESEARCH |
2016 | Phase I dose escalation study of helical intensity-modulated radiotherapy-based stereotactic body radiotherapy for hepatocellular carcinoma
| ONCOTARGET |
2019 | Phase I/II trial of helical IMRT-based stereotactic body radiotherapy for hepatocellular carcinoma | DIGESTIVE AND LIVER DISEASE |
2014 | Phase IIb multicentred randomised trial of besifovir (LB80380) versus entecavir in Asian patients with chronic hepatitis B | GUT |
2008 | Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis.
| CANCER |
2007 | PIVKA-II Is a Useful Tumor Marker for Recurrent Hepatocellular Carcinoma after Surgical Resection | ONCOLOGY |
2014 | Pre-S mutations of hepatitis B virus affect genome replication and expression of surface antigens | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2016 | Predicting Liver-Related Events Using Transient Elastography in Chronic Hepatitis C Patients with Sustained Virological Response.
| GUT AND LIVER |
2014 | Prediction of development of liver-related events by transient elastography in Hepatitis B patients with complete virological response on antiviral therapy | AMERICAN JOURNAL OF GASTROENTEROLOGY |
2012 | Prediction of esophageal variceal bleeding in B-viral liver cirrhosis using the P2/MS noninvasive index based on complete blood counts. | DIGESTION |
2012 | Prediction of liver-related events using fibroscan in chronic hepatitis B patients showing advanced liver fibrosis
| PLOS ONE |
2008 | Prediction of microvascular invasion before curative resection of hepatocellular carcinoma | JOURNAL OF SURGICAL ONCOLOGY |
2008 | Prediction of postoperative hepatic insufficiency by liver stiffness measurement (FibroScan((R))) before curative resection of hepatocellular carcinoma: a pilot study
| HEPATOLOGY INTERNATIONAL |
2012 | Prediction of recurrence after curative resection of hepatocellular carcinoma using liver stiffness measurement (FibroScan®) | ANNALS OF SURGICAL ONCOLOGY |
2011 | Prediction of significant fibrosis in chronic hepatitis C patients with normal ALT | HEPATO-GASTROENTEROLOGY |
2016 | Prediction of virologic response to tenofovir mono-rescue therapy for multidrug resistant chronic hepatitis B | JOURNAL OF MEDICAL VIROLOGY |
2011 | Predictive factors for long-term survival in patients with clinically significant portal hypertension following resection of hepatocellular carcinoma | LIVER INTERNATIONAL |
2016 | Predictive Factors of Spontaneous Bacterial Peritonitis Caused by Gram-Positive Bacteria in Patients With Cirrhosis
| MEDICINE |
2019 | Predictive validation of qualitative fibrosis staging in patients with chronic hepatitis B on antiviral therapy
| SCIENTIFIC REPORTS |
2012 | Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg-negative carriers | LIVER INTERNATIONAL |
2008 | Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with chronic hepatitis B | JOURNAL OF CLINICAL GASTROENTEROLOGY |
2019 | Predictors of Discordance in the Assessment of Skeletal Muscle Mass between Computed Tomography and Bioimpedance Analysis
| JOURNAL OF CLINICAL MEDICINE |
2018 | Predictors of failure to detect early hepatocellular carcinoma in patients with chronic hepatitis B who received regular surveillance | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
2013 | Predictors of Refractory Ascites Development in Patients with Hepatitis B Virus-Related Cirrhosis Hospitalized to Control Ascitic Decompensation
| YONSEI MEDICAL JOURNAL |
2009 | Preoperative radiologic and postoperative pathologic risk factors for early intra-hepatic recurrence in hepatocellular carcinoma patients who underwent curative resection
| YONSEI MEDICAL JOURNAL |
2008 | Prevalence and genotype distribution of hepatitis C virus among apparently healthy individuals in Mongolia: a population-based nationwide study. | LIVER INTERNATIONAL |
2017 | Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease | DIGESTIVE DISEASES AND SCIENCES |
2011 | Prevention of hepatocellular carcinoma in patients with chronic hepatitis B virus infection | ONCOLOGY |
2015 | Prevention of hepatocellular carcinoma: beyond hepatitis B vaccination | SEMINARS IN ONCOLOGY |
2004 | Primary liver carcinoma of intermediate (hepatocyte–cholangiocyte) phenotype | JOURNAL OF HEPATOLOGY |
2017 | Pro-tumorigenic roles of TGF-β signaling during the early stages of liver tumorigenesis through upregulation of Snail
| BMB REPORTS |
2014 | Prognosis of hepatocellular carcinoma patients with extrahepatic metastasis and the controllability of intrahepatic lesions | CLINICAL & EXPERIMENTAL METASTASIS |
2019 | Prognosis of Untreated Minimally Active Chronic Hepatitis B Patients in Comparison With Virological Responders by Antivirals | CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY |
2017 | Prognostic factors of sorafenib therapy in hepatocellular carcinoma patients with failure of transarterial chemoembolization | HEPATOLOGY INTERNATIONAL |
2014 | Prognostic Indicators for Acute Liver Failure Development and Mortality in Patients with Hepatitis A: Consecutive Case Analysis
| YONSEI MEDICAL JOURNAL |
2015 | Prognostic role of magnetic resonance imaging vs. computed tomography for hepatocellular carcinoma undergoing chemoembolization | LIVER INTERNATIONAL |
2013 | Prognostic significance of the worst grade in hepatocellular carcinoma with heterogeneous histologic grades of differentiation | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2011 | Prognostic value of 18F-FDG PET for hepatocellular carcinoma patients treated with sorafenib | LIVER INTERNATIONAL |
2021 | Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma
| YONSEI MEDICAL JOURNAL |
2017 | Prognostic Value of FDG Uptake of Portal Vein Tumor Thrombosis in Patients With Locally Advanced Hepatocellular Carcinoma | CLINICAL NUCLEAR MEDICINE |
2013 | Prognostic Value of Model for End-Stage Liver Disease Scores in Patients with Fulminant Hepatic Failure | TRANSPLANTATION PROCEEDINGS |
2011 | Prognostic value of the 7th edition of the AJCC staging system as a clinical staging system in patients with hepatocellular carcinoma. | EUROPEAN JOURNAL OF CANCER |
2015 | Prognostic value of the combined use of transient elastography and fibrotest in patients with chronic hepatitis B | LIVER INTERNATIONAL |
2013 | Prognostic value of α-fetoprotein and des-γ-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization
| BMC CANCER |
2019 | Progression of Untreated Minimally Active Chronic HBV Infection Compared to Inactive Infection | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
2020 | Proposal of a New Risk Score for Patients Treated with Transarterial Chemoembolization due to Recurrent Hepatocellular Carcinoma after Curative Resection: A Multicenter Study
| GUT AND LIVER |
2013 | Prospective comparison of prognostic values of modified Response Evaluation Criteria in Solid Tumours with European Association for the Study of the Liver criteria in hepatocellular carcinoma following chemoembolisation | EUROPEAN JOURNAL OF CANCER |